Skip to main content

Advertisement

Log in

Quantitative Dynamic Models of Arthritis Progression in the Rat

  • Research Article
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

This comparison employs mathematical disease progression models to identify a rat model of arthritis with the least inter-animal variability and features lending to better study designs.

Methods

Arthritis was induced with either collagen (CIA) or mycobacterium (AIA) in either Lewis or Dark Agouti (DA) rats. Disease progression was monitored by paw edema and body weight. Models with production, loss, and feedback components were constructed and population analysis using NONMEM software was employed to identify inter-animal variability in the various disease progression parameters.

Results

Onset time was the only parameter different within all four groups (DA–AIA 11.5 days, DA–CIA 16.5 days, Lewis–AIA 11.9 days, Lewis–CIA 13.9 days). The loss-of-edema rate constant was 20% slower in DA (0.362 h−1) than Lewis (0.466 h−1) rats. Most models exhibited peak paw edema 20 days post-induction. Edema in CIA returned to 150% of the initial value after the disease peaked. DA rats displayed more severe overall responses.

Conclusions

No statistical differences between groups were observed for inter-animal variation in disease onset, progression and severity parameters. Onset time varies and should be noted in the design of future studies. DA rats may offer a more dynamic range of edema response than Lewis rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

AIA:

adjuvant-induced arthritis

CIA:

collagen-induced arthritis

CV:

coefficient of variation

FOCE:

first order conditional estimation

MVOF:

minimum value of the objective function

PD:

pharmacodynamics

PK:

pharmacokinetics

RA:

rheumatoid arthritis

k out :

loss of edema rate constant

k in :

production of edema rate constant

R deg :

loss of production of edema rate constant

t Onset :

disease onset time

P :

parameter

θ :

population mean of P

η :

measure of individual’s deviation from θ

References

  1. R. Holmdahl, J. C. Lorentzen, S. Lu, P. Olofsson, L. Wester, J. Holmberg, and U. Pettersson. Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol. Rev. 184:184–202 (2001) doi:10.1034/j.1600-065x.2001.1840117.x.

    Article  PubMed  CAS  Google Scholar 

  2. S. S. Kerwar, N. Bauman, A. L. Oronsky, and A. E. Sloboda. Studies on type II collagen induced polyarthritis in rats. Effect of complement depletion. J. Immunopharmacol. 3:323–337 (1981).

    Article  PubMed  CAS  Google Scholar 

  3. C. M. Pearson. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc. Soc. Exp. Biol. Med. 91:95–101 (1956).

    PubMed  CAS  Google Scholar 

  4. J. M. Stuart, M. A. Cremer, A. S. Townes, and A. H. Kang. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J. Exp. Med. 155:1–16 (1982) doi:10.1084/jem.155.1.1.

    Article  PubMed  CAS  Google Scholar 

  5. J. D. A. Taurog, D. C. Argentieri, and R. A. McReynolds. Adjuvant arthritis. Methods Enzymol. 162:339–355 (1956) doi:10.1016/0076-6879(88)62089-1.

    Article  Google Scholar 

  6. J. R. Ward, and R. S. Jones. Studies on adjuvant-induced polyarthritis in rats. I. Adjuvant composition, route of injection, and removal of depot site. Arthritis Rheum. 5:557–564 (1962) doi:10.1002/art.1780050604.

    Article  PubMed  CAS  Google Scholar 

  7. P. H. Wooley. The usefulness and the limitations of animal models in identifying targets for therapy in arthritis. Best Pract. Res. Clin. Rheumatol. 18:47–58 (2004) doi:10.1016/j.berh.2003.09.007.

    Article  PubMed  CAS  Google Scholar 

  8. S. Akilesh, S. Petkova, T. J. Sproule, D. J. Shaffer, G. J. Christianson, and D. Roopenian. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J. Clin. Invest. 113:1328–1333 (2004).

    PubMed  CAS  Google Scholar 

  9. J. S. Courtenay, M. J. Dallman, A. D. Dayan, A. Martin, and B. Mosedale. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 283:666–668 (1980) doi:10.1038/283666a0.

    Article  PubMed  CAS  Google Scholar 

  10. D. E. Trentham, A. S. Townes, and A. H. Kang. Autoimmunity to type II collagen an experimental model of arthritis. J. Exp. Med. 146:857–868 (1977) doi:10.1084/jem.146.3.857.

    Article  PubMed  CAS  Google Scholar 

  11. O. Kohashi, K. Aihara, A. Ozawa, S. Kotani, and I. Azuma. New model of a synthetic adjuvant, N-acetylmuramyl-l-alanyl-d-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats. Lab Invest. 47:27–36 (1982).

    PubMed  CAS  Google Scholar 

  12. O. Kohashi, C. M. Pearson, Y. Watanabe, and S. Kotani. Preparation of arthritogenic hydrosoluble peptidoglycans from both arthritogenic and non-arthritogenic bacterial cell walls. Infect. Immun. 16:861–866 (1977).

    PubMed  CAS  Google Scholar 

  13. F. C. Colpaert, T. Meert, P. De Witte, and P. Schmitt. Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat. Life Sci. 31:67–75 (1982) doi:10.1016/0024-3205(82)90402-7.

    Article  PubMed  CAS  Google Scholar 

  14. R. Holmdahl, C. Vingsbo, V. Malmstrom, L. Jansson, and M. Holmdahl. Chronicity of arthritis induced with homologous type II collagen (CII) in rats is associated with anti-CII B-cell activation. J. Autoimmun. 7:739–752 (1994) doi:10.1006/jaut.1994.1058.

    Article  PubMed  CAS  Google Scholar 

  15. P. Larsson, S. Kleinau, R. Holmdahl, and L. Klareskog. Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum. 33:693–701 (1990) doi:10.1002/art.1780330512.

    Article  PubMed  CAS  Google Scholar 

  16. C. M. W. Pearson, and F. M. Wood. Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. I. General clinical and pathologic characteristics and some modifying factors. Arthritis Rheum. 2:440–459 (1959) doi:10.1002/1529-0131(195910)2:5<440::AID-ART1780020510>3.0.CO;2-N.

    Article  Google Scholar 

  17. K. A. Bush, B. W. Kirkham, and J. S. Walker. The in vivo effects of tumour necrosis factor blockade on the early cell mediated immune events and syndrome expression in rat adjuvant arthritis. Clin. Exp. Immunol. 127:423–429 (2002) doi:10.1046/j.1365-2249.2002.01742.x.

    Article  PubMed  CAS  Google Scholar 

  18. D. W. Hunt, L. Corson, H. D. Barker, J. G. Levy, and R. E. Petty. Relationship between collagen-induced and adjuvant arthritis in the Lewis rat. J. Autoimmun. 6:691–700 (1993) doi:10.1006/jaut.1993.1058.

    Article  PubMed  CAS  Google Scholar 

  19. G. S. Panayi, J. S. Lanchbury, and G. H. Kingsley. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum. 35:729–735 (1992) doi:10.1002/art.1780350702.

    Article  PubMed  CAS  Google Scholar 

  20. S. S. Kerwar, M. E. Englert, R. A. McReynolds, M. J. Landes, J. M. Lloyd, A. L. Oronsky, and F. J. Wilson. Type II collagen-induced arthritis. Studies with purified anticollagen immunoglobulin. Arthritis Rheum. 26:1120–1131 (1983) doi:10.1002/art.1780260910.

    Article  PubMed  CAS  Google Scholar 

  21. I. Rioja, K. A. Bush, J. B. Buckton, M. C. Dickson, and P. F. Life. Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin. Exp. Immunol. 137:65–73 (2004) doi:10.1111/j.1365-2249.2004.02499.x.

    Article  PubMed  CAS  Google Scholar 

  22. E. Larsson, A. Mussener, D. Heinegard, L. Klareskog, and T. Saxne. Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. Br. J. Rheumatol. 36:1258–1261 (1997) doi:10.1093/rheumatology/36.12.1258.

    Article  PubMed  CAS  Google Scholar 

  23. J. M. Stuart, K. Tomoda, T. J. Yoo, A. S. Townes, and A. H. Kang. Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum. 26:1237–1244 (1983) doi:10.1002/art.1780261011.

    Article  PubMed  CAS  Google Scholar 

  24. K. Takagishi, N. Kaibara, T. Hotokebuchi, C. Arita, M. Morinaga, and K. Arai. Serum transfer of collagen arthritis in congenitally athymic nude rats. J. Immunol. 134:3864–3867 (1985).

    PubMed  CAS  Google Scholar 

  25. P. Wernhoff, C. Unger, E. Bajtner, H. Burkhardt, and R. Holmdahl. Identification of conformation-dependent epitopes and V gene selection in the B cell response to type II collagen in the DA rat. Int. Immunol. 13:909–919 (2001) doi:10.1093/intimm/13.7.909.

    Article  PubMed  CAS  Google Scholar 

  26. J. C. Lorentzen, and L. Klareskog. Comparative susceptibility of DA, LEW, and LEW.1AV1 rats to arthritis induced with different arthritogens: mineral oil, mycobacteria, muramyl dipeptide, avridine and rat collagen type II. Transplant. Proc. 29:1692–1693 (1997) doi:10.1016/S0041-1345(97)00018-3.

    Article  PubMed  CAS  Google Scholar 

  27. C. M. Rubino, E. V. Capparelli, J. S. Bradley, J. L. Blumer, G. L. Kearns, M. Reed, R. F. Jacobs, B. Cirincione, and D. M. Grasela. Population pharmacokinetic model for gatifloxacin in pediatric patients. Antimicrob. Agents Chemother. 51:1246–1252 (2007) doi:10.1128/AAC.00685-06.

    Article  PubMed  CAS  Google Scholar 

  28. U. Wählby, E. N. Jonsson, and M. O. Karlsson. Assessment of actual significance levels for covariate effects in NONMEM. J. Pharmacokinet. Pharmacodyn. 28:231–252 (2001).

    Article  PubMed  Google Scholar 

  29. M. Dimitrijevic, O. Laban, V. J. Djuric, S. Stanojevic, T. Miletic, V. Kovacevic-Jovanovic, C. Todorovic, and J. Radulovic. Behavior and severity of adjuvant arthritis in four rat strains. Brain Behav. Immun. 15:255–265 (2001) doi:10.1006/brbi.2000.0599.

    Article  PubMed  CAS  Google Scholar 

  30. G. W. Cannon, M. L. Woods, F. Clayton, and M. M. Griffiths. Induction of arthritis in DA rats by incomplete Freund’s adjuvant. J. Rheumatol. 20:7–11 (1993).

    PubMed  CAS  Google Scholar 

  31. S. Carlsen, A. S. Hansson, H. Olsson, D. Heinegard, and R. Holmdahl. Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin. Exp. Immunol. 114:477–484 (1998) doi:10.1046/j.1365-2249.1998.00739.x.

    Article  PubMed  CAS  Google Scholar 

  32. R. Holmdahl, T. J. Goldschmidt, S. Kleinau, C. Kvick, and R. Jonsson. Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease. Immunology. 76:197–202 (1992).

    PubMed  CAS  Google Scholar 

  33. S. Kleinau, H. Erlandsson, R. Holmdahl, and L. Klareskog. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J. Autoimmun. 4:871–880 (1991) doi:10.1016/0896-8411(91)90050-M.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William J. Jusko.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Earp, J.C., DuBois, D.C., Almon, R.R. et al. Quantitative Dynamic Models of Arthritis Progression in the Rat. Pharm Res 26, 196–203 (2009). https://doi.org/10.1007/s11095-008-9711-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-008-9711-3

KEY WORDS

Navigation